270 related articles for article (PubMed ID: 19225146)
41. Action of ondansetron and CP-99,994 on cisplatin-induced emesis and locomotor activity in Suncus murinus (house musk shrew).
Lau AH; Rudd JA; Yew DT
Behav Pharmacol; 2005 Dec; 16(8):605-12. PubMed ID: 16286811
[TBL] [Abstract][Full Text] [Related]
42. Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT
Rudd JA; Chan SW; Ngan MP; Tu L; Lu Z; Giuliano C; Lovati E; Pietra C
Front Pharmacol; 2018; 9():869. PubMed ID: 30127745
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat.
Horn CC; De Jonghe BC; Matyas K; Norgren R
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1375-82. PubMed ID: 19710391
[TBL] [Abstract][Full Text] [Related]
44. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
Darmani NA
J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
[TBL] [Abstract][Full Text] [Related]
45. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
Darmani NA; Chebolu S; Amos B; Alkam T
Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
[TBL] [Abstract][Full Text] [Related]
46. L-type calcium channels contribute to 5-HT3-receptor-evoked CaMKIIα and ERK activation and induction of emesis in the least shrew (Cryptotis parva).
Hutchinson TE; Zhong W; Chebolu S; Wilson SM; Darmani NA
Eur J Pharmacol; 2015 May; 755():110-8. PubMed ID: 25748600
[TBL] [Abstract][Full Text] [Related]
47. Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer.
Einhorn LH; Brames MJ; Dreicer R; Nichols CR; Cullen MT; Bubalo J
Support Care Cancer; 2007 Nov; 15(11):1293-1300. PubMed ID: 17436025
[TBL] [Abstract][Full Text] [Related]
48. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
[TBL] [Abstract][Full Text] [Related]
49. 5-Hydroxytryptamine is emetogenic in the house musk shrew, Suncus murinus.
Torii Y; Saito H; Matsuki N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):564-7. PubMed ID: 1725807
[TBL] [Abstract][Full Text] [Related]
50. Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus.
Horn CC
Auton Neurosci; 2009 Jun; 148(1-2):76-82. PubMed ID: 19362521
[TBL] [Abstract][Full Text] [Related]
51. Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis.
Zhong W; Chebolu S; Darmani NA
Eur J Pharmacol; 2021 Jun; 900():174065. PubMed ID: 33775646
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of antiemetic effect of various dosage regimens of azasetron hydrochloride based on 5-HT3 receptor occupancy of serotonin].
Yamada Y; Fujita M; Okuyama K; Takayanagi R; Ozeki T; Yokoyama H; Iga T
Yakugaku Zasshi; 2007 Feb; 127(2):353-7. PubMed ID: 17268155
[TBL] [Abstract][Full Text] [Related]
53. Acute oxycodone induces the pro-emetic pica response in rats.
Batra VR; Schrott LM
J Pharmacol Exp Ther; 2011 Dec; 339(3):738-45. PubMed ID: 21875950
[TBL] [Abstract][Full Text] [Related]
54. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
[TBL] [Abstract][Full Text] [Related]
55. Absence of emetic effects of morphine and loperamide in Suncus murinus.
Selve N; Friderichs E; Reimann W; Reinartz S
Eur J Pharmacol; 1994 May; 256(3):287-93. PubMed ID: 8045273
[TBL] [Abstract][Full Text] [Related]
56. The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).
Tu L; Lu Z; Ngan MP; Lam FFY; Giuliano C; Lovati E; Pietra C; Rudd JA
Br J Pharmacol; 2020 Apr; 177(7):1635-1650. PubMed ID: 31722444
[TBL] [Abstract][Full Text] [Related]
57. A phase II randomised study to evaluate the efficacy of aprepitant plus palonosetron for preventing delayed-phase CINV associated with TC therapy in gynaecological cancer.
Sugimori Y; Ota T; Ujihira T; Ishiguro T; Ogishima D
J Obstet Gynaecol Res; 2017 Sep; 43(9):1454-1459. PubMed ID: 28952201
[TBL] [Abstract][Full Text] [Related]
58. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
59. Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: a new experimental model.
Matsuki N; Ueno S; Kaji T; Ishihara A; Wang CH; Saito H
Jpn J Pharmacol; 1988 Oct; 48(2):303-6. PubMed ID: 3210455
[TBL] [Abstract][Full Text] [Related]
60. 2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus.
Sticht MA; Rock EM; Parker LA
Physiol Behav; 2013 Aug; 120():228-32. PubMed ID: 23958470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
